ArticleOncotarget2017
Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.
Sanaz Taromi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it